134 related articles for article (PubMed ID: 15821350)
21. Altered p16INK4a and Fhit expression in carcinogenesis and progression of human oral cancer.
Paradiso A; Ranieri G; Stea B; Zito A; Zehbe I; Tommasino M; Grammatica L; De Lena M
Int J Oncol; 2004 Feb; 24(2):249-55. PubMed ID: 14719099
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical detection of X-linked inhibitor of apoptosis in head and neck squamous cell carcinoma.
Nagi C; Xiao GQ; Li G; Genden E; Burstein DE
Ann Diagn Pathol; 2007 Dec; 11(6):402-6. PubMed ID: 18022123
[TBL] [Abstract][Full Text] [Related]
23. [Galectins in squamous cell carcinomas of the head and neck cancers].
Cada Z; Plzák J; Chovanec M; Dvoránková B; Lacina L; Szabó P; Smetana K; Betka J
Cas Lek Cesk; 2008; 147(11):559-63. PubMed ID: 19097359
[TBL] [Abstract][Full Text] [Related]
24. Expression of Ulex europaeus agglutinin I lectin-binding sites in squamous cell carcinomas and their absence in basal cell carcinomas. Indicator of tumor type and differentiation.
Heng MC; Fallon-Friedlander S; Bennett R
Am J Dermatopathol; 1992 Jun; 14(3):216-9. PubMed ID: 1380781
[TBL] [Abstract][Full Text] [Related]
25. Variations of EGF-R surface expression in squamous cell carcinomas of the head and neck region.
Mandic R; Eikelkamp N; Peldszus R; Sadowski M; Sesterhenn AM; Dünne AA; Werner JA
Anticancer Res; 2001; 21(5):3413-8. PubMed ID: 11848502
[TBL] [Abstract][Full Text] [Related]
26. The role of frozen section histological analysis in the treatment of head and neck skin basal and squamous cell carcinomas.
Bogdanov-Berezovsky A; Rosenberg L; Cagniano E; Silberstein E
Isr Med Assoc J; 2008 May; 10(5):344-5. PubMed ID: 18605355
[TBL] [Abstract][Full Text] [Related]
27. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
[TBL] [Abstract][Full Text] [Related]
28. Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium.
Irjala H; Alanen K; Grénman R; Heikkilä P; Joensuu H; Jalkanen S
Cancer Res; 2003 Aug; 63(15):4671-6. PubMed ID: 12907648
[TBL] [Abstract][Full Text] [Related]
29. AgNORs in squamous cell carcinoma of head and neck.
Arora B; Jeevan D; Punia RS; Kumar S; Arora DR
J Indian Med Assoc; 2002 May; 100(5):315-6. PubMed ID: 12418633
[TBL] [Abstract][Full Text] [Related]
30. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.
Mukunyadzi P; Liu K; Hanna EY; Suen JY; Fan CY
Mod Pathol; 2003 Aug; 16(8):796-801. PubMed ID: 12920224
[TBL] [Abstract][Full Text] [Related]
31. Role of cytokines in head and neck squamous cell carcinoma.
Pries R; Nitsch S; Wollenberg B
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1195-203. PubMed ID: 17020454
[TBL] [Abstract][Full Text] [Related]
32. Tumor angiogenesis.
Petruzzelli GJ
Head Neck; 1996; 18(3):283-91. PubMed ID: 8860771
[TBL] [Abstract][Full Text] [Related]
33. The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases.
Doxtader EE; Katzenstein AL
Hum Pathol; 2012 Mar; 43(3):327-32. PubMed ID: 21840041
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation.
Lu SL; Reh D; Li AG; Woods J; Corless CL; Kulesz-Martin M; Wang XJ
Cancer Res; 2004 Jul; 64(13):4405-10. PubMed ID: 15231647
[TBL] [Abstract][Full Text] [Related]
35. Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis.
Kotelnikov VM; Coon JS; Mundle S; Kelanic S; LaFollette S; Taylor S IV; Hutchinson J; Panje W; Caldarelli DD; Preisler HD
Clin Cancer Res; 1997 Jan; 3(1):95-101. PubMed ID: 9815543
[TBL] [Abstract][Full Text] [Related]
36. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma.
Kyzas PA; Geleff S; Batistatou A; Agnantis NJ; Stefanou D
J Pathol; 2005 Jun; 206(2):170-7. PubMed ID: 15846845
[TBL] [Abstract][Full Text] [Related]
37. Adhesion molecules in cancer of the head and neck: role of dysadherin.
Giotakis I; Chrysovergis A; Georgolios A; Giotakis E; Manolopoulos L
J BUON; 2011; 16(4):609-12. PubMed ID: 22331710
[TBL] [Abstract][Full Text] [Related]
38. Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.
Kinoshita T; Nohata N; Watanabe-Takano H; Yoshino H; Hidaka H; Fujimura L; Fuse M; Yamasaki T; Enokida H; Nakagawa M; Hanazawa T; Okamoto Y; Seki N
Int J Oncol; 2012 Jun; 40(6):1770-8. PubMed ID: 22378351
[TBL] [Abstract][Full Text] [Related]
39. Retinoic acid receptor beta induces terminal differentiation of squamous cell carcinoma lines in the absence of cyclin-dependent kinase inhibitor expression.
Crowe DL
Cancer Res; 1998 Jan; 58(1):142-8. PubMed ID: 9426070
[TBL] [Abstract][Full Text] [Related]
40. [Basement membrane laminin in head and neck squamous cell carcinoma and its significance in therapy].
Kuratomi Y
Nihon Jibiinkoka Gakkai Kaiho; 2002 Jun; 105(6):721-6. PubMed ID: 12182149
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
